Dr Hans Krecise

Assist. Head of Research and Development

Personal Data

Nationality
United Kingdom

Year of Birth
1976

Dr. Hans Krecise serves as the Assistant Head of Research and Development, playing a vital role in supporting and driving the strategic initiatives of the R&D division. With a strong background in biomedical sciences and a focus on translational research, Dr. Krecise bridges the gap between cutting-edge scientific discoveries and their practical application in drug development.

Educational Background

Dr. Krecise holds a Ph.D. in Molecular Biology from the University of Heidelberg, where his research focused on cellular signaling pathways in cancer. His academic foundation is further strengthened by a Master’s degree in Biochemistry, providing him with a comprehensive understanding of the molecular mechanisms underlying human diseases.

Professional Experience

Dr. Krecise’s career spans over two decades in the pharmaceutical industry, with extensive experience in both research and leadership roles:

• Early Career: Dr. Krecise began his career as a research scientist, contributing to groundbreaking studies in oncology and immunology. His work led to several high-impact publications and early-stage drug candidates.

• Leadership Roles: As his career progressed, Dr. Krecise took on more significant responsibilities, including leading multidisciplinary teams in drug discovery and preclinical development. His ability to integrate scientific research with strategic planning has been instrumental in advancing several promising therapeutic candidates to clinical trials.

• Current Role: In his current role as Assistant Head of Research and Development, Dr. Krecise collaborates closely with the Head of R&D, overseeing key projects and initiatives. He plays a crucial role in managing the R&D pipeline, ensuring that the division’s goals align with the company’s overall strategy. His focus includes fostering innovation, streamlining processes, and mentoring the next generation of scientists.

•  

Research Interests

Dr. Krecise is passionate about translational research, particularly in the fields of oncology, immunotherapy, and personalized medicine. He advocates for a patient-centered approach, aiming to develop therapies that are not only effective but also tailored to individual patient needs. His work often explores the intersection of genetics and drug response, seeking to understand how genetic variations can influence treatment outcomes.

Contributions and Impact

• Innovative Projects: Dr. Krecise has been involved in several high-profile projects that have led to the development of novel therapies, some of which are now in advanced stages of clinical trials. His contributions have significantly impacted the company’s R&D capabilities, particularly in the areas of precision medicine and targeted therapies.

• Scientific Community Engagement: Beyond his work at the company, Dr. Krecise is an active member of the scientific community. He regularly participates in international conferences and contributes to peer-reviewed journals. His expertise is sought after for advisory boards and collaborative research projects.

• Mentorship and Leadership: Dr. Krecise is committed to fostering a culture of innovation and excellence within the R&D team. He actively mentors young scientists, encouraging them to pursue innovative ideas and take on leadership roles within the organization.

Personal Philosophy

Dr. Krecise believes in the power of science to transform lives. His approach to research is driven by a deep commitment to improving patient outcomes through innovative therapies. He is known for his collaborative spirit, working across disciplines to harness the collective expertise of his team and partners in the broader scientific community.

Dr. Hans Krecise’s blend of scientific expertise, leadership, and strategic vision makes him a key figure in the ongoing efforts to advance research and development in the pharmaceutical industry.

4o